Jianning Zhai

1.7k total citations · 2 hit papers
15 papers, 1.0k citations indexed

About

Jianning Zhai is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jianning Zhai has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Jianning Zhai's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jianning Zhai is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Jianning Zhai collaborates with scholars based in Hong Kong, China and Canada. Jianning Zhai's co-authors include Jun Yu, Huarong Chen, Wei Kang, Hongyan Gou, Yasi Pan, Chi Chun Wong, Weixin Liu, Cong Liang, Dan Huang and Shiyan Wang and has published in prestigious journals such as Gastroenterology, Cancer Research and Oncogene.

In The Last Decade

Jianning Zhai

15 papers receiving 1.0k citations

Hit Papers

METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE... 2022 2026 2023 2024 2022 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
    2022 181 citations Huarong Chen, Yasi Pan et al. Gastroenterology profile →
  2. Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
    2023 154 citations Yi Bao, Jianning Zhai et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianning Zhai Hong Kong 10 818 435 211 145 87 15 1.0k
Arabella Wan China 10 1.1k 1.3× 632 1.5× 133 0.6× 59 0.4× 126 1.4× 18 1.2k
Marc B. Bissonnette United States 10 1.3k 1.5× 656 1.5× 310 1.5× 243 1.7× 110 1.3× 12 1.5k
Haibiao Xie China 15 723 0.9× 504 1.2× 110 0.5× 68 0.5× 36 0.4× 30 904
Longfei Dai China 10 611 0.7× 349 0.8× 109 0.5× 49 0.3× 90 1.0× 28 748
Ruiyan Wu China 10 817 1.0× 437 1.0× 210 1.0× 63 0.4× 86 1.0× 24 1.0k
Song Zhao China 16 459 0.6× 216 0.5× 143 0.7× 96 0.7× 25 0.3× 31 734
Jiang Shi China 14 619 0.8× 446 1.0× 75 0.4× 50 0.3× 21 0.2× 25 753
Huiwen Song China 9 588 0.7× 277 0.6× 68 0.3× 44 0.3× 93 1.1× 11 759
Beibei Liu China 13 477 0.6× 225 0.5× 164 0.8× 65 0.4× 12 0.1× 46 711

Countries citing papers authored by Jianning Zhai

Since Specialization
Citations

This map shows the geographic impact of Jianning Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianning Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianning Zhai more than expected).

Fields of papers citing papers by Jianning Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianning Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianning Zhai. The network helps show where Jianning Zhai may publish in the future.

Co-authorship network of co-authors of Jianning Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Jianning Zhai. A scholar is included among the top collaborators of Jianning Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianning Zhai. Jianning Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bao, Yi Wang, Jianning Zhai, Huarong Chen, et al.. (2023). Mo1258 TARGETING M6A READER YTHDF1 AUGMENTS ANTITUMOR IMMUNITY AND BOOSTS ANTI-PD-1 EFFICACY IN COLORECTAL CANCER. Gastroenterology. 164(6). S–803. 1 indexed citations
2.
Bao, Yi, Jianning Zhai, Huarong Chen, et al.. (2023). Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 72(8). 1497–1509. 154 indexed citations breakdown →
3.
Gou, Hongyan, Chi Chun Wong, Huarong Chen, et al.. (2023). TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer. Cancer Letters. 578. 216438–216438. 13 indexed citations
4.
Zhai, Jianning, Huarong Chen, Chi Chun Wong, et al.. (2023). ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy. Gastroenterology. 165(2). 445–462. 88 indexed citations
5.
Zhai, Jianning, Huarong Chen, Yasi Pan, et al.. (2023). Mo1257 ALKBH5 DRIVES IMMUNE SUPPRESSION VIA TARGETING AXIN2 TO PROMOTE COLORECTAL CANCER AND IS A TARGET FOR BOOSTING IMMUNOTHERAPY. Gastroenterology. 164(6). S–803. 2 indexed citations
6.
Pan, Yasi, Huarong Chen, Xiang Zhang, et al.. (2023). METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Reports Medicine. 4(8). 101144–101144. 91 indexed citations
7.
Chen, Huarong, Yasi Pan, Qiming Zhou, et al.. (2022). METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 163(4). 891–907. 181 indexed citations breakdown →
8.
Bai, Xiaowu, Chi Chun Wong, Yasi Pan, et al.. (2022). Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells. Journal for ImmunoTherapy of Cancer. 10(2). e003663–e003663. 75 indexed citations
9.
Bai, Xiaowu, Chi Chun Wong, Huarong Chen, et al.. (2021). 366 YTHDF1 SUPPRESSES ANTI-TUMOR IMMUNITY THROUGH INHIBITING THE MATURATION OF DENDRITIC CELLS IN GASTRIC CANCER. Gastroenterology. 160(6). S–70. 1 indexed citations
10.
Zhang, Jingwan, Jianning Zhai, Chi Chun Wong, et al.. (2021). A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML). Oncogene. 40(49). 6641–6652. 7 indexed citations
11.
Wang, Shiyan, Chi Chun Wong, Yanquan Zhang, et al.. (2021). ZNF545 loss promotes ribosome biogenesis and protein translation to initiate colorectal tumorigenesis in mice. Oncogene. 40(48). 6590–6600. 12 indexed citations
12.
Liu, Jinkai, Wei Geng, Hanyong Sun, et al.. (2021). Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma. Gut. 71(6). 1203–1213. 83 indexed citations
13.
Chen, Huarong, Shanshan Gao, Weixin Liu, et al.. (2020). RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target. Gastroenterology. 160(4). 1284–1300.e16. 231 indexed citations
14.
Wang, Shiyan, Junzhe Huang, Chuangen Li, et al.. (2019). MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer. Clinical Cancer Research. 26(3). 746–757. 8 indexed citations
15.
Wang, Shiyan, Yanquan Zhang, Junzhe Huang, et al.. (2019). TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression. Cancer Research. 79(16). 4086–4098. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arabella Wan Breakdown of academic impact, for papers by Marc B. Bissonnette Breakdown of academic impact, for papers by Haibiao Xie Breakdown of academic impact, for papers by Longfei Dai Breakdown of academic impact, for papers by Ruiyan Wu Breakdown of academic impact, for papers by Song Zhao Breakdown of academic impact, for papers by Jiang Shi Breakdown of academic impact, for papers by Huiwen Song Breakdown of academic impact, for papers by Beibei Liu
Rankless by CCL
2026